NASDAQ
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a market cap of $5.84M as of Thursday, May 21, 2026. The LIMN market cap is up 19.24% over the past 30 days and has declined 96.49% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.